Of the other validated genes, only one has previously been associated with cytotoxic chemotherapy response in other cancers: somatic variants in SYNE1, which codes for a nuclear envelope-associated protein [30], correlated with poor response to induction chemotherapy in head and neck cancer [31]. This evidence concerns the gene SYNE1 and head and neck cancer.